Literature DB >> 17160066

Mechanisms of fear extinction.

K M Myers1, M Davis.   

Abstract

Excessive fear and anxiety are hallmarks of a variety of disabling anxiety disorders that affect millions of people throughout the world. Hence, a greater understanding of the brain mechanisms involved in the inhibition of fear and anxiety is attracting increasing interest in the research community. In the laboratory, fear inhibition most often is studied through a procedure in which a previously fear conditioned organism is exposed to a fear-eliciting cue in the absence of any aversive event. This procedure results in a decline in conditioned fear responses that is attributed to a process called fear extinction. Extensive empirical work by behavioral psychologists has revealed basic behavioral characteristics of extinction, and theoretical accounts have emphasized extinction as a form of inhibitory learning as opposed to an erasure of acquired fear. Guided by this work, neuroscientists have begun to dissect the neural mechanisms involved, including the regions in which extinction-related plasticity occurs and the cellular and molecular processes that are engaged. The present paper will cover behavioral, theoretical and neurobiological work, and will conclude with a discussion of clinical implications.

Entities:  

Mesh:

Year:  2006        PMID: 17160066     DOI: 10.1038/sj.mp.4001939

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  441 in total

Review 1.  Molecular specificity of multiple hippocampal processes governing fear extinction.

Authors:  Jelena Radulovic; Natalie C Tronson
Journal:  Rev Neurosci       Date:  2010       Impact factor: 4.353

2.  Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking.

Authors:  Liping Chen; Ming Xu
Journal:  J Neurochem       Date:  2010-04-28       Impact factor: 5.372

3.  Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice.

Authors:  Kiersten S Smith; Edward G Meloni; Karyn M Myers; Ashlee Van't Veer; William A Carlezon; Uwe Rudolph
Journal:  Psychopharmacology (Berl)       Date:  2010-10-05       Impact factor: 4.530

Review 4.  Pharmacological enhancement of drug cue extinction learning: translational challenges.

Authors:  K M Kantak; B Á Nic Dhonnchadha
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 5.  Virtual Reality-Enhanced Extinction of Phobias and Post-Traumatic Stress.

Authors:  Jessica L Maples-Keller; Carly Yasinski; Nicole Manjin; Barbara Olasov Rothbaum
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

6.  Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Yasushi Yabuki; Ibuki Takahata; Kazuya Matsuo; Yuji Owada; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

Review 7.  From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.

Authors:  Michael B VanElzakker; M Kathryn Dahlgren; F Caroline Davis; Stacey Dubois; Lisa M Shin
Journal:  Neurobiol Learn Mem       Date:  2013-12-07       Impact factor: 2.877

Review 8.  Developmental rodent models of fear and anxiety: from neurobiology to pharmacology.

Authors:  Despina E Ganella; Jee Hyun Kim
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  Immune status influences fear and anxiety responses in mice after acute stress exposure.

Authors:  Sarah M Clark; Joseph Sand; T Chase Francis; Anitha Nagaraju; Kerry C Michael; Achsah D Keegan; Alexander Kusnecov; Todd D Gould; Leonardo H Tonelli
Journal:  Brain Behav Immun       Date:  2014-02-10       Impact factor: 7.217

10.  Augmentation of exposure therapy with post-session administration of D-cycloserine.

Authors:  Candyce D Tart; Pamela R Handelsman; Lindsey B Deboer; David Rosenfield; Mark H Pollack; Stefan G Hofmann; Mark B Powers; Michael W Otto; Jasper A J Smits
Journal:  J Psychiatr Res       Date:  2012-10-23       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.